Skip to main content

and
  1. Article

    Open Access

    Effect of disease duration on fecal biomarkers in ulcerative colitis: a prospective cohort study

    Biomarkers such as fecal calprotectin (FC) and fecal immunochemical occult blood tests (FIT) for ulcerative colitis (UC) are used in clinical practice. In this study, the effect of UC disease duration on FC wa...

    Natsuki Ishida, Masanao Kaneko, Yusuke Asai, Takahiro Miyazu in BMC Gastroenterology (2022)

  2. Article

    Open Access

    Further research on the clinical relevance of the ulcerative colitis colonoscopic index of severity for predicting 5-year relapse

    The ulcerative colitis colonoscopic index of severity (UCCIS) evaluates the state of the entire colonic mucosa in ulcerative colitis. However, no cut-off values of scores for predicting clinical relapse in pat...

    Natsuki Ishida, Shunya Onoue in International Journal of Colorectal Disease (2021)

  3. No Access

    Article

    Effect of ulcerative colitis duration on the usefulness of immunochemical fecal occult blood test result as a disease activity biomarker

    The effects of ulcerative colitis (UC) duration on biomarker accuracy are unknown. We investigated the effects of UC duration on the predictive accuracy of biomarkers including immunochemical fecal occult bloo...

    Natsuki Ishida, Takahiro Miyazu in International Journal of Colorectal Disease (2020)

  4. Article

    Open Access

    Prostaglandin E-major urinary metabolite versus fecal immunochemical occult blood test as a biomarker for patient with ulcerative colitis

    Prostaglandin E-major urinary metabolite (PGE-MUM) may be a novel biomarker for evaluating disease activity in ulcerative colitis (UC). We compared its usefulness to that of the fecal immunochemical occult blo...

    Natsuki Ishida, Takahiro Miyazu, Ryosuke Takano, Satoshi Tamura in BMC Gastroenterology (2020)